litlas
Log inCreate account

Rafael Esteban

Active 1989–2024

96
Papers
18,507
Citations
72
h-index
93
i10-index

Citations

Citations per year for Rafael Esteban1979: 1 citations1986: 2 citations1989: 3 citations1990: 25 citations1991: 42 citations1992: 56 citations1993: 34 citations1994: 42 citations1995: 43 citations1996: 29 citations1997: 49 citations1998: 40 citations1999: 60 citations2000: 89 citations2001: 112 citations2002: 119 citations2003: 105 citations2004: 104 citations2005: 71 citations2006: 96 citations2007: 86 citations2008: 105 citations2009: 66 citations2010: 94 citations2011: 108 citations2012: 113 citations2013: 127 citations2014: 139 citations2015: 110 citations2016: 97 citations2017: 74 citations2018: 81 citations2019: 279 citations2020: 329 citations2021: 321 citations2022: 194 citations2023: 132 citations2024: 218 citations2025: 82 citations2026: 3 citations1980–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,288 citing papers, 22.8% of this breakdownSpain: 382 citing papers, 6.8% of this breakdownItaly: 378 citing papers, 6.7% of this breakdownUnited Kingdom: 365 citing papers, 6.4% of this breakdownFrance: 350 citing papers, 6.2% of this breakdownGermany: 348 citing papers, 6.1% of this breakdownChina: 228 citing papers, 4% of this breakdownJapan: 211 citing papers, 3.7% of this breakdownCanada: 197 citing papers, 3.5% of this breakdownTaiwan: 149 citing papers, 2.6% of this breakdownAustralia: 139 citing papers, 2.5% of this breakdownSwitzerland: 133 citing papers, 2.4% of this breakdown
0%22.8%Other 26.3%

Institutions

Fields

  • Medicine93.7%
  • Biochemistry, Genetics and Molecular Biology2.5%
  • Immunology and Microbiology0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Agricultural and Biological Sciences0.5%
  • Neuroscience0.3%
  • Other1.5%

Topics

  • Hepatitis C virus research20%
  • Liver Disease Diagnosis and Treatment14.8%
  • Hepatitis B Virus Studies14.4%
  • Liver Disease and Transplantation8.1%
  • Hepatitis Viruses Studies and Epidemiology3.7%
  • Organ Transplantation Techniques and Outcomes2.7%
  • Other36.3%

Coauthors

All papers

Open in search
  1. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

    Authors: George Papatheodoridis, George Ν. Dalekos, Vana Sypsa, Cihan Yurdaydın, Marı́a Buti, John Goulis, José Luís Calleja, Heng Chi, Spilios Manolakopoulos, Giampaolo Mangia, Nikolaos Gatselis, Onur Keskın, Savvoula Savvidou, Juan de la Revilla, Bettina E. Hansen, Jiannis Vlachogiannakos, Kostantinos Galanis, Ramazan Idılman, M. Colombo, Rafael Esteban, Harry L.A. Janssen, Pietro Lampertico - Journal of Hepatology 2015 cited by 541

  2. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D

    Authors: Adriana Palom, Ariadna Rando‐Segura, Judit Vico, Beatriz Pacín Ruiz, Elena Cachicatari Vargas, Ana Barreira‐Díaz, Francisco Rodríguez-Frías, Mar Riveiro‐Barciela, Rafael Esteban, Marı́a Buti - JHEP Reports 2022 cited by 97

  3. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

    Authors: George Papatheodoridis, Ramazan Idılman, George Ν. Dalekos, Marı́a Buti, Heng Chi, Florian van Bömmel, José Luís Calleja, Vana Sypsa, John Goulis, Spilios Manolakopoulos, Alessandro Loglio, Spyros I. Siakavellas, Onur Keskın, Nikolaos Gatselis, Bettina E. Hansen, Maria Lehretz, Juan de la Revilla, Savvoula Savvidou, Anastasia Κourikou, Jiannis Vlachogiannakos, Kostantinos Galanis, Cihan Yurdaydın, Thomas Berg, Massimo Colombo, Rafael Esteban, Harry L.A. Janssen, Pietro Lampertico - Hepatology 2017 cited by 292

  4. Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors

    Authors: Mar Riveiro‐Barciela, Ana Barreira‐Díaz, Judit Vidal‐González, Eva Muñoz‐Couselo, Fernando Martínez‐Valle, L Viladomiu, Beatriz Mínguez, Carolina Ortiz, Lluı́s Castells, Rafael Esteban, Marı́a Buti - Liver International 2020 cited by 65

  5. Thrombocytopenia associated with chronic liver disease

    Authors: Nezam H. Afdhal, John G. McHutchison, Robert S. Brown, Ira M. Jacobson, Michael P. Manns, Fred Poordad, Babette B. Weksler, Rafael Esteban - Journal of Hepatology 2008 cited by 576

  6. Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

    Authors: Íñigo Les, Eduardo Doval, Rita García‐Martínez, M. Planas, Guillermo Cárdenas, Pilar Gómez, Montse Flavià, Carlos Jacas, Beatriz Mínguez, Mercedes Vergara, Germán Soriano, Carmen Vila, Rafael Esteban, Juan Córdoba - The American Journal of Gastroenterology 2011 cited by 184

  7. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind study

    Authors: Macarena Simón‐Talero, Rita García‐Martínez, María Torrens, Salvador Augustín, Susana Gómez, Gustavo Pereira, Mónica Guevara, Pere Ginès, Germán Soriano, Eva Román, Jordi Sánchez‐Delgado, Roser Ferrer, Juan C. Nieto, Pilar Sunyé, Inmaculada Fuentes-Durá, Rafael Esteban, Juan Córdoba - Journal of Hepatology 2013 cited by 127

  8. Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

    Authors: Jordi Llaneras, Mar Riveiro‐Barciela, Sabela Lens, M. Diago, Alba Cachero, Javier García‐Samaniego, Isabel Conde, Ana Arencibía, Juan Arenas, Francisco Gea, Xavier Torras, José Luís Calleja, J.A. Carrión, Inmaculada Fernández, Rosa M. Morillas, José Miguel Rosales Zábal, Isabel Carmona, Conrado Fernández‐Rodríguez, Manuel Hernández‐Guerra, Susana Llerena, Vanesa Bernal Monterde, Juan Turnés, Jesús M. González‐Santiago, Silvia Montoliu, Blanca Figueruela, Ester Badía, Manuel Delgado, Miguel Fernández‐Bermejo, Mercedes Iñarrairaegui, J.M. Pascasio, Rafael Esteban, Zoe Mariñó, Marı́a Buti - Journal of Hepatology 2019 cited by 100

  9. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study

    Authors: Juan Córdoba, Juan López-Hellı́n, M. Planas, Pilar Sabı́n, Francesc Sanpedro, Francisco Castro, Rafael Esteban, Jaume Guàrdia - Journal of Hepatology 2004 cited by 473

  10. Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis

    Authors: Sergio Borgia, Janet Dearden, Eric M. Yoshida, Stephen D. Shafran, Ashley Brown, Ziv Ben‐Ari, Matthew Cramp, Curtis Cooper, Matthew Foxton, Conrado Fernández‐Rodríguez, Rafael Esteban, Robert H. Hyland, Sophia Lu, Brian J. Kirby, Amy Meng, Svetlana Markova, Hadas Dvory‐Sobol, Anu Osinusi, Rafael Bruck, Javier Ampuero, Stephen Ryder, Kosh Agarwal, Raymond G. Fox, David Shaw, Shariq Haider, Bernard Willems, Yoav Lurie, José Luís Calleja, Edward Gane - Journal of Hepatology 2019 cited by 123

  11. Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B

    Authors: George Papatheodoridis, George Ν. Dalekos, Ramazan Idılman, Vana Sypsa, Florian van Bömmel, Marı́a Buti, José Luís Calleja, John Goulis, Spilios Manolakopoulos, Alessandro Loglio, Μargarita Papatheodoridi, Nikolaos Gatselis, Rhea Veelken, Marta López-Gómez, Bettina E. Hansen, Savvoula Savvidou, Anastasia Κourikou, Jiannis Vlachogiannakos, Kostas Galanis, Cihan Yurdaydın, Rafael Esteban, Harry L.A. Janssen, Thomas Berg, Pietro Lampertico - Journal of Hepatology 2020 cited by 88

  12. Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

    Authors: Stefan Zeuzem, Geoffrey Dusheiko, Riina Salupere, Alessandra Mangia, Robert Flisiak, Robert H. Hyland, Ari Illeperuma, Evguenia S. Svarovskaia, Diana M. Brainard, William T. Symonds, G. Mani Subramanian, John G. McHutchison, Ola Weiland, Hendrik W. Reesink, Péter Ferenci, Christophe Hézode, Rafael Esteban - New England Journal of Medicine 2014 cited by 798

  13. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

    Authors: George Papatheodoridis, George Ν. Dalekos, Cihan Yurdaydın, Marı́a Buti, John Goulis, P. Arends, Vana Sypsa, Spilios Manolakopoulos, Giampaolo Mangia, Nikolaos Gatselis, Onur Keskın, Savvoula Savvidou, Bettina E. Hansen, Christos Papaioannou, Kostantinos Galanis, Ramazan Idılman, Massimo Colombo, Rafael Esteban, Harry L.A. Janssen, Pietro Lampertico - Journal of Hepatology 2014 cited by 156

  14. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study

    Authors: Marı́a Buti, María Homs, Francisco Rodríguez‐Frias, G. Funalleras, Rosendo Jardí, Sílvia Sauleda, David Tabernero, M. Schaper, Rafael Esteban - Journal of Viral Hepatitis 2010 cited by 156

  15. Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

    Authors: Cihan Yurdaydın, Zaigham Abbas, Marı́a Buti, Markus Cornberg, Rafael Esteban, Ohad Etzion, Edward Gane, Robert G. Gish, Jeffrey S. Glenn, Saeed Hamid, Theo Heller, Christopher Koh, Pietro Lampertico, Yoav Lurie, Michael P. Manns, Raymundo Paraná, Mario Rizzetto, Stephan Urban, Heiner Wedemeyer, Anika Wranke, Lourdes Maria Pinheiro Borzacov, Cirley Lobato, Saeed Hamid, Emanoil Ceaușu, George Ν. Dalekos, Adela Turcanu, Grazia Anna Niro, Farheen Lubna, Minaam Abbas, Patrick Ingiliz, Péter Ferenci, Thomas Vanwolleghem, Tonya Hayden, Naranjargal Dashdorj, Adriana Moţoc, Svenja Hardtke - Journal of Hepatology 2018 cited by 115

  16. Long‐term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

    Authors: Adriana Palom, Sergio Rodríguez‐Tajes, C.A. Navascués, Javier García‐Samaniego, Mar Riveiro‐Barciela, Sabela Lens, Manuel Rodríguez, Rafael Esteban, Marı́a Buti - Alimentary Pharmacology & Therapeutics 2019 cited by 84

  17. Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis

    Authors: Marı́a Buti, Raquel Domínguez‐Hernández, Adriana Palom, Rafael Esteban, Miguel Á. Casado - Liver International 2023 cited by 22

  18. Effectiveness of Combined Pharmacologic and Ligation Therapy in High-Risk Patients With Acute Esophageal Variceal Bleeding

    Authors: Salvador Augustín, José Altamirano, Antonio González, Joan Dot, Monder Abu–Suboh, J Armengol, Fernando Azpiroz, Rafael Esteban, Jaime Guardia, Joan Genescà - The American Journal of Gastroenterology 2011 cited by 147

  19. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B

    Authors: George Papatheodoridis, Vana Sypsa, George Ν. Dalekos, Cihan Yurdaydın, Florian van Bömmel, Marı́a Buti, José Luís Calleja, Heng Chi, John Goulis, Spilios Manolakopoulos, Alessandro Loglio, Theodoros Voulgaris, Nikolaos Gatselis, Onur Keskın, Rhea Veelken, Marta López-Gómez, Bettina E. Hansen, Savvoula Savvidou, Anastasia Κourikou, John Vlachogiannakos, Kostas Galanis, Ramazan Idılman, Rafael Esteban, Harry L.A. Janssen, Thomas Berg, Pietro Lampertico - Journal of Hepatology 2020 cited by 100

  20. One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease

    Authors: Adriana Palom, Sara Sopena, Mar Riveiro‐Barciela, Ângela Carvalho‐Gomes, Antonio Madejón, Sergio Rodríguez‐Tajes, Luisa Roade, María García‐Eliz, Javier García‐Samaniego, Sabela Lens, Marina Berenguer, Francisco Rodríguez‐Frias, Helena Hernández‐Évole, Ana Gil-García, Ana Barreira, Rafael Esteban, Marı́a Buti - Alimentary Pharmacology & Therapeutics 2021 cited by 46

  21. Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

    Authors: Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz, Patrick Marcellin, John M. Vierling, Stefan Zeuzem, Fred Poordad, Zachary Goodman, Heather L. Sings, Navdeep Boparai, Margaret Burroughs, Clifford A. Brass, Janice K. Albrecht, Rafael Esteban - New England Journal of Medicine 2011 cited by 1,614

  22. Cardiac alterations in cirrhosis: reversibility after liver transplantation

    Authors: Mireia Torregrosa, Santi Aguadé, Laura Dos, Rosa Segura, Antonio González, Artur Evangelista, Joan Martí i Castell, Carlos Margarit, Rafael Esteban, Jaume Guàrdia, Joan Genescà - Journal of Hepatology 2004 cited by 322

  23. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis

    Authors: Rosa María Pérez‐Ayuso, J. M. Piqué, Jaime Bosch, Enrique Quintero, R. Valderrama, Josep M. Bordas, J. Rodés, Julián Panés, J.M. Viver, Antonio González, Rafael Esteban, R. Pérez, Luı́s Rodrigo, Joaquín Rigau - The Lancet 1991 cited by 280

  24. Quality of life in cirrhosis is related to potentially treatable factors

    Authors: Íñigo Les, Eduardo Doval, Montserrat Flavià, Carlos Jacas, Guillermo Cárdenas, Rafael Esteban, Jaime Guardia, Juan Córdoba - European Journal of Gastroenterology & Hepatology 2010 cited by 148